$1.14/ day, billed weekly
Cancel anytime

(Ads Free, Unlimited access)

NO CREDIT CARD REQUIRED

Qsam Biosciences Inc (QSAM)QSAM

Qsam Biosciences Inc

$8.3

Delayed price

Profit since last BUY15.28%

Consider higher Upturn Star rating

BUY since 33 days

BUY Advisory
Profitable SELL
Loss-Inducing SELL

Profit
Loss
PASS (Skip invest)*

Time period over

ALL
YEAR
MONTH
WEEK

Time period over

Upturn Advisory Summary

05/02/2024: QSAM (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance

Type: Stock	Upturn Star Rating	Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -81.06%	Upturn Advisory Performance 2	Avg. Invested days: 22
Profits based on simulation	Stock Returns Performance 1	Last Close 05/02/2024

Type: Stock	Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -81.06%	Avg. Invested days: 22
Upturn Star Rating	Stock Returns Performance 1
Profits based on simulation Last Close 05/02/2024	Upturn Advisory Performance 2

Key Highlights

Company Size Small-Cap Stock	Market Capitalization 36.90M USD
Price to earnings Ratio -	1Y Target Price -
Dividends yield (FY) -	Basic EPS (TTM) -1.69
Volume (30-day avg) 11761	Beta 1.81
52 Weeks Range 4.00 - 8.49	Updated Date 05/3/2024

Company Size Small-Cap Stock	Market Capitalization 36.90M USD	Price to earnings Ratio -	1Y Target Price -
Dividends yield (FY) -	Basic EPS (TTM) -1.69	Volume (30-day avg) 11761	Beta 1.81
52 Weeks Range 4.00 - 8.49	Updated Date 05/3/2024

Earnings Date

Report Date -	When -
Estimate -	Actual -

Report Date -

When -

Estimate -

Actual -

Profitability

Profit Margin -

Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -238.09%

Return on Equity (TTM) -3377.07%

Valuation

Trailing PE -	Forward PE -
Enterprise Value 36027704	Price to Sales(TTM) 1.71
Enterprise Value to Revenue 18.26	Enterprise Value to EBITDA -8.02
Shares Outstanding 4445470	Shares Floating 2065365
Percent Insiders 52.36	Percent Institutions -

Trailing PE -	Forward PE -	Enterprise Value 36027704	Price to Sales(TTM) 1.71
Enterprise Value to Revenue 18.26	Enterprise Value to EBITDA -8.02	Shares Outstanding 4445470	Shares Floating 2065365
Percent Insiders 52.36	Percent Institutions -

Analyst Ratings

Rating -	Target Price -	Buy -
Strong Buy -	Hold -	Sell -
Strong Sell -

Rating -	Target Price -	Buy -	Strong Buy -
Hold -	Sell -	Strong Sell -

About Qsam Biosciences Inc

Exchange	NASDAQ	Headquaters	Austin, TX, United States
IPO Launch date	2015-12-11	Co-Founder, CEO & Director	Mr. Douglas R. Baum
Sector	Healthcare	Website	https://qsambio.com
Industry	Biotechnology	Full time employees	4
Headquaters	Austin, TX, United States
Co-Founder, CEO & Director	Mr. Douglas R. Baum
Website	https://qsambio.com
Website	https://qsambio.com
Full time employees	4

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.